You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 5, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Xavier Fradera1,2, Michael H Reutershan3,4, Michelle R Machacek3
1Computational and Structural Chemistry, Merck & Co., Inc, Boston, MA and Kenilworth, NJ, USA.
We developed an automated workflow using Nuclear Magnetic Resonance (NMR) data to model protein-ligand complexes. This method accurately predicts binding poses for drug discovery, as demonstrated with HDM2 protein inhibitors.
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: